Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Toshiki Hyodo"'
Autor:
Toshiki Hyodo, Chonji Fukumoto, Yuta Sawatani, Sayaka Izumi, Michiko Shimura, Yuske Komiyama, Hitoshi Kawamata, Masayo Hitomi-Koide, Ryota Kamimura, Koh-ichi Nakashiro, Daisuke Uchida, Shuma Yagisawa, Tomonori Hasegawa, Erika Yaguchi
Publikováno v:
In Vivo. 34:3233-3240
Background/aim Odontogenic diseases are diagnosed based on clinical course, imaging, and histopathology. However, a definitive diagnosis is not always possible. Patients and methods We analyzed whole exons of SMO, BRAF, PTCH1 and GNAS using next-gene
Autor:
Hitoshi Kawamata, Yuske Komiyama, Ryouta Kamimura, Chonji Fukumoto, Ryo Oshima, Yuta Sawatani, Tomonori Hasegawa, Atsushi Fujita, Takahiro Wakui, Sayaka Izumi, Toshiki Hyodo, Ryo Shiraishi
Publikováno v:
Cancers; Volume 13; Issue 22; Pages: 5843
Cancers
Cancers, Vol 13, Iss 5843, p 5843 (2021)
Cancers
Cancers, Vol 13, Iss 5843, p 5843 (2021)
Simple Summary Surveillance methods for oral squamous cell carcinoma (OSCC) patients may be chosen by considering the risk of recurrence. We performed a retrospective cohort study in 324 OSCC patients after complete surgical resection as the primary
Autor:
Chonji Fukumoto, Toshiki Hyodo, Yuta Sawatani, Ryouta Kamimura, Michiko Shimura, Hitoshi Kawamata, Daisuke Uchida, Nobuyuki Kuribayashi, Koh-ichi Nakashiro, Tomonori Hasegawa, Atsushi Fujita
Publikováno v:
Oncology Letters
Molecules that demonstrate a clear association with the aggressiveness of oral squamous cell carcinoma (OSCC) have not yet been identified. The current study hypothesized that tumor cells in OSCC have three different origins: Epithelial stem cells, o
Autor:
Yuske Komiyama, Ryouta Kamimura, Tomonori Hasegawa, Chonji Fukumoto, Daisuke Uchida, Toshiki Hyodo, Hitoshi Kawamata, Masayo Hitomi-Koide, Michiko Shimura, Koh-ichi Nakashiro, Yuta Sawatani
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 6292, p 6292 (2020)
Volume 21
Issue 17
International Journal of Molecular Sciences, Vol 21, Iss 6292, p 6292 (2020)
Volume 21
Issue 17
Administration of cetuximab (C-mab) in combination with paclitaxel (PTX) has been used for patients with head and neck squamous cell carcinoma (SCC) clinically. In this study, we attempted to clarify the molecular mechanisms of the enhancing anticanc